KalVista Pharmaceuticals
KALV
KALV
105 hedge funds and large institutions have $408M invested in KalVista Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 33 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
28% less capital invested
Capital invested by funds: $567M → $408M (-$159M)
85% less call options, than puts
Call options by funds: $533K | Put options by funds: $3.54M
Holders
105
Holding in Top 10
–
Calls
$533K
Puts
$3.54M
Top Buyers
| 1 | +$6.15M | |
| 2 | +$3.88M | |
| 3 | +$2.74M | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$2.24M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$2.18M |
Top Sellers
| 1 | -$7.57M | |
| 2 | -$6.22M | |
| 3 | -$4.71M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$3.86M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$2.54M |